MDS Pharma Services has named Patrice Hugo as vice president of scientific affairs for its global central lab network, the company announced this week.
In this role, Hugo will lead the development of biomarkers and assays to enhance clinical development productivity from Phases I through IV.
Hugo was previously executive vice president of research and development at Caprion Proteomics. From 1997 to 2003, he was vice president of scientific research and then chief scientific officer at Procrea BioSciences. Prior to Procrea, Hugo worked for the Institut de Recherches Cliniques de Montreal (Montreal Institute of Clinical Research).
Fluorotechnics has named former GE Healthcare Biosciences President David Weber as non-executive director.
Weber was most recently chief executive officer and president of Eksigent Technologies. Prior to Ekisigent, he was the vice president of global marketing and business development for Stratagene.
Weber has also held senior executive roles with Chemdex, Amersham Biosciences, and Pharmacia Biotech.